Sanigen KRX:188260KOSDAQ

세니젠 · Korean news coverage and regulatory filings, organized.

Articles, 24h0
Articles, 7 days0
DART filings, 7 days1
Articles tracked7since Sep 11

In Q3 2026, Sanigen reported revenue of ₩4.2bn, up 3.8% year on year, and an operating loss of ₩438m. Sanigen (세니젠) appeared in 0 Korean news articles and 1 DART filing over the past seven days.

Filing signals 4 quarters of losses Screener

Sanigen today: up or down?

No sign-up, one tap a day. These numbers show what visitors think and are not investment advice.

Upcoming dates as filed

  • Mar 31 Annual report filing deadlinein 135 days · period ending Dec 2026

Dates Sanigen stated in its DART filings. A conversion period opening does not mean new shares appear that day; bondholders must request conversion.

Sanigen quarterly results separate, KRW

QuarterRevenueYoYOperating profitNet income
Q3 2026₩4.2bn+3.8%−₩438m
margin −10.4%
−₩682m
Q2 2026₩3.8bn-55.5%−₩405m
margin −10.6%
−₩145m
Q1 2026₩3.3bn-56.9%−₩872m
margin −26.3%
−₩898m
Q4 2025 derived check units−₩4.9bn–−₩1.8bn−₩3.2bn
Q3 2025₩4.1bn-38.5%−₩908m
margin −22.4%
−₩937m
Q2 2025₩8.6bn+50.8%−₩791m
margin −9.2%
−₩812m
Q1 2025₩7.7bn+62.2%−₩891m
margin −11.6%
−₩904m
Q4 2024 derived check units−₩1.6bn–−₩1.8bn−₩2.5bn

Sanigen ranks #1610 of 2,345 Korean listed companies by Q3 2026 operating profit. Q3 2026 Korean earnings rankings →

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Sanigen top stories 2 weeks, by number of outlets

No story covered by multiple outlets in the past two weeks.

Latest Sanigen news Korean headlines